- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04734093
Sonographic Signs of Gouty Arthritis in a Cohort of Egyptian Patients: a Cross Sectional Multicenter Study
May 2, 2021 updated by: Ahmed Mahrous, Sohag University
The study is a cross sectional observational multicenter study.
It is established in collaboration with the Egyptian college of rheumatology study group (ECRsg).
It is conditioned that all the study participants had either mono- or oligo-arthritis with effusion of the knee or the first metatarsophalangeal (MTP) joint in patients with a known history of gout or at high risk.
Patients with any known chronic arthritis, comprising rheumatoid arthritis, Sjogren's syndrome, systemic lupus erythematosus, scleroderma, neuropathic arthritis, seronegative spondyloarthropathy, will be excluded from the study.
None of the participants had a history of intra-articular injection or aspiration in the scanned joints for 3 months prior to the inclusion in the study.
The sonographers will be blinded for clinical data and the EULAR scanning protocol for the knee and 1st MTP will be considered [2].
Further, scanning of the double contour sign over the femur condyles anteriorly and posteriorly in sagittal planes will be assessed.
All the sonographers in the study had an experience between 5 and 10 years in the field of musculoskeletal ultrasound.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
سوهاج
-
Sohag, سوهاج, Egypt, 82749
- Ahmed Elsaman
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The study population will be collected from several university clinics all over Egypt.
All are aged 40 or more with a history of definite gouty arthritis or at high risk and they have active arthritis of at least one joint.
Description
Inclusion Criteria:
- mono- or oligo-arthritis with effusion of the knee or the first metatarsophalangeal
- patients with a known history of gout or at high risk
Exclusion Criteria:
- Patients with any known chronic arthritis, comprising rheumatoid arthritis, Sjoegren's syndrome, systemic lupus erythematosus, scleroderma, neuropathic arthritis, seronegative spondyloarthropathy
- History of intra-articular injection in the last 3 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Sohag university recruited patients
|
the EULAR scanning protocol for the knee and 1st MTP will be considered [2].
Further, scanning of the double contour sign over the femur condyles anteriorly and posteriorly in sagittal planes will be assessed.
Examination of erosions, tophus, double contour, effusion, and echogenic foci will be recorded.
|
|
Minia university recruited patients
|
the EULAR scanning protocol for the knee and 1st MTP will be considered [2].
Further, scanning of the double contour sign over the femur condyles anteriorly and posteriorly in sagittal planes will be assessed.
Examination of erosions, tophus, double contour, effusion, and echogenic foci will be recorded.
|
|
Assuit university recruited patients
|
the EULAR scanning protocol for the knee and 1st MTP will be considered [2].
Further, scanning of the double contour sign over the femur condyles anteriorly and posteriorly in sagittal planes will be assessed.
Examination of erosions, tophus, double contour, effusion, and echogenic foci will be recorded.
|
|
Kasr Elini recruited patients
|
the EULAR scanning protocol for the knee and 1st MTP will be considered [2].
Further, scanning of the double contour sign over the femur condyles anteriorly and posteriorly in sagittal planes will be assessed.
Examination of erosions, tophus, double contour, effusion, and echogenic foci will be recorded.
|
|
Tanta university recruited patients
|
the EULAR scanning protocol for the knee and 1st MTP will be considered [2].
Further, scanning of the double contour sign over the femur condyles anteriorly and posteriorly in sagittal planes will be assessed.
Examination of erosions, tophus, double contour, effusion, and echogenic foci will be recorded.
|
|
Monofia university recruited patients
|
the EULAR scanning protocol for the knee and 1st MTP will be considered [2].
Further, scanning of the double contour sign over the femur condyles anteriorly and posteriorly in sagittal planes will be assessed.
Examination of erosions, tophus, double contour, effusion, and echogenic foci will be recorded.
|
|
Aswan university recruited patients
|
the EULAR scanning protocol for the knee and 1st MTP will be considered [2].
Further, scanning of the double contour sign over the femur condyles anteriorly and posteriorly in sagittal planes will be assessed.
Examination of erosions, tophus, double contour, effusion, and echogenic foci will be recorded.
|
|
Ain shams university recruited patients
|
the EULAR scanning protocol for the knee and 1st MTP will be considered [2].
Further, scanning of the double contour sign over the femur condyles anteriorly and posteriorly in sagittal planes will be assessed.
Examination of erosions, tophus, double contour, effusion, and echogenic foci will be recorded.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sonographic signs of gouty arthritis in the knee or 1st MTP joint
Time Frame: at baseline
|
Erosions, effusion, echogenic foci, and tophus using OMERACT definitions of sonographic signs of gouty arthritis
|
at baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 15, 2020
Primary Completion (Actual)
April 16, 2021
Study Completion (Actual)
April 16, 2021
Study Registration Dates
First Submitted
January 28, 2021
First Submitted That Met QC Criteria
January 28, 2021
First Posted (Actual)
February 2, 2021
Study Record Updates
Last Update Posted (Actual)
May 4, 2021
Last Update Submitted That Met QC Criteria
May 2, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21130
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.